UNSPSC 51473601: Benzoxiquine

This classification denotes an anti-infective agent with the molecular formula C16H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GRE0P19C3Z, chemically known as 8-quinolinol, benzoate (ester) but generally known as benzoxiquine, which bears US NIH Compound Identifier 6855. European Medicines Agency schedules Benzoxiquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05763MIG.

UNSPSC 51473601 Benzoxiquine (Commodity) encompasses chemical compounds and active pharmaceutical ingredients used in medical and operational contexts across state and local government facilities, though recent solicitation activity shows limited direct purchasing of benzoxiquine itself. State and local procurement under this code reflects broader demand for consumable supplies in public safety and healthcare settings rather than focused acquisition of a single chemical agent. Issuing bodies include county governments and state purchasing alliances administering multi-jurisdictional cooperative purchasing programs. The mix skews toward county commissioners' offices managing fire rescue operations and state departments of administration coordinating pharmaceutical and OTC product procurement across multiple member entities.

Recent activity centers on two distinct purchasing models. Hillsborough County Board of County Commissioners posted ITB 2600319 on July 7, 2026 (due July 24, 2026) for consumable janitorial and operational supplies estimated at $765,679.84 annually to support 47 fire stations operated by Hillsborough County Fire Rescue, with delivery required to Tampa, Florida. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, including Oregon, with products to be available by May 15, 2026 and contracts effective July 1, 2026. The Minnesota opportunity required vendors to supply through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, Morris & Dickson Co., LLC) and comply with FDA requirements, cGMP, and Drug Supply Chain Security Act standards. Recent activity appears concentrated in Florida and Minnesota-led multi-state cooperative purchasing frameworks rather than dispersed across numerous jurisdictions.